Robust B-cell depletion observed with budoprutug subcutaneous formulation in healthy volunteers, supporting continued developmentBudoprutug pMN, ...
MedPage Today on MSN
FDA Claims 'Manipulated' Data Led to Drug's Approval, Proposes Withdrawal
Pivotal trial on avacopan was negative before actions of unblinded study personnel, agency ...
A 76-year-old woman, who had a history of treated hepatitis C virus infection, presented with rapidly progressive kidney failure and a stroke. Palpable purpura on the legs was noted. A diagnosis ...
May is National Cancer Research Month a time to highlight the vital importance of scientific research in saving lives for ...
Izicopan is an investigational next-generation oral C5aR1 inhibitor designed to achieve differentiated pharmacological properties, with the potential for improved efficacy and safety. The marketed ...
Among patients with AAV who develop DAH, a subset also experience VTE, highlighting the complex care required to manage this population.
FDA proposes to withdraw Amgen's Tavneos for autoimmune diseases due to lack of effectiveness and safety concerns.
Imaging analyses can improve diagnostic accuracy and confidence in patients with giant cell arteritis, according to data ...
Research found that vaccinated individuals were 46 per cent less likely to suffer major cardiac events. Doctors explain what ...
ILD was detected in about half of AAV cases, and one-third had fibrotic ILD, indicating a substantial pulmonary fibrosis burden within routine vasculitis care. Microscopic polyangiitis carried the ...
Tue, Apr 28, 2026 The Department for Work and Pensions (DWP) has released a list of medical conditions that have seen people ...
His eyes were nearly fixed in the primary position, with slight preservation of vertical gaze but no horizontal gaze ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results